enVVeno Medical Corporation
enVVeno Medical Corporation (NVNO): 3 pipeline candidates · ~22 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
22.2 months
D/E 0.10 · 0% dilution
Lead: Phase 3
3 candidates
N/A
0 buys · 1 sell (180d)
A transparent, data-derived signal for enVVeno Medical Corporationacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$7.0M
Cash
$2.6M
Quarterly Burn
$3.2M
Runway
22.2 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
| Drug | Phase |
|---|---|
| envve | Preclinical |
| envve system | Preclinical |
| venovalve | Phase 3 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
12
Total value held
$643K
| Holder | Shares | Value |
|---|---|---|
| kingdon capital management, l.l.c. | 36,166 | $366K |
| vanguard capital management llc | 12,574 | $127K |
| geode capital management, llc | 10,455 | $106K |
| vanguard fiduciary trust co | 2,184 | $22K |
| blackrock, inc. | 1,840 | $19K |
| wells fargo & company/mn | 114 | $1K |
| vanguard global advisers, llc | 77 | $780 |
| morgan stanley | 76 | $770 |
| osaic holdings, inc. | 7 | $70 |
| group one trading llc | 2 | $20 |
Showing top 10 of 12 institutional holders of enVVeno Medical Corporation. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in enVVeno Medical Corporation's pipeline?
enVVeno Medical Corporation (NVNO) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is enVVeno Medical Corporation's lead drug candidate?
enVVeno Medical Corporation's most advanced tracked candidate is envve (Preclinical) for Severe Chronic Venous Insufficiency (CVI) of the deep venous system of the leg.
What is enVVeno Medical Corporation's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, enVVeno Medical Corporation has approximately 22.2 months of cash runway.
What is enVVeno Medical Corporation's market capitalization?
enVVeno Medical Corporation's market capitalization is approximately $7.0M.
Who is the CEO of enVVeno Medical Corporation?
Mr. Robert A. Berman is the chief executive officer of enVVeno Medical Corporation (NVNO).
Get the full picture on enVVeno Medical Corporation
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.